Pedro Garbes
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Renal Transplantation Outcomes and Treatments
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 1
-
- RNA Interference and Gene Delivery 1
- Co-authors
- Francisco Padilla (1 shared paper)Douglas Arbetter (1 shared paper)Essack Mitha (1 shared paper)Sonia Kounlavouth (1 shared paper)Meghan G. Hart (1 shared paper)Richard Hobbs (1 shared paper)Lucas Kraemer (1 shared paper)Gavin Koh (1 shared paper)
- Partner nations
- United KingdomSouth AfricaUnited States
In The Last Decade
Pedro Garbes
1 paper receiving 127 citations
Pedro Garbes's Hit Papers
Peers
Comparison fields: 5 of 41
- Infectious Diseases 115
- Transplantation 8
- Neurology 25
- Critical Care and Intensive Care Medicine 5
- Oncology 22
Countries citing papers authored by Pedro Garbes
This map shows the geographic impact of Pedro Garbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Garbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Garbes more than expected).
Fields of papers citing papers by Pedro Garbes
This network shows the impact of papers produced by Pedro Garbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Garbes. The network helps show where Pedro Garbes may publish in the future.
Co-authors
The 25 scholars most cited alongside Pedro Garbes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2022 | 127 |
| 2 | 2023 | 0 |
About Pedro Garbes
Pedro Garbes is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Immunology and Organic Chemistry, having authored 2 papers that have together received 127 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (1 paper), Respiratory viral infections research (1 paper), Immunotherapy and Immune Responses (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Infectious Diseases (115 citations), Transplantation (8 citations), Neurology (25 citations), Critical Care and Intensive Care Medicine (5 citations) and Oncology (22 citations). Pedro Garbes has collaborated with scholars based in United Kingdom, South Africa and United States. Frequent co-authors include Francisco Padilla, Douglas Arbetter, Essack Mitha, Sonia Kounlavouth, Meghan G. Hart, Richard Hobbs, Lucas Kraemer, Gavin Koh, Katie Streicher and Kelly Padilla. Their work appears in journals such as Open Forum Infectious Diseases and The Lancet Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.